Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 2 Way ANOVA examining intra-subject macular volume change pre-op and 5 weeks post-op, also between NSAID and placebo groups with all patients and with those having risk factors

From: Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo

  2-Way ANOVA with replication
All patients macular volume P-value
Post-operative volume change 0.032
NSAID vs. placebo volume change 0.858
Patients with Risk Factors macular vol. P-value
Post-operative volume change 0.003
NSAID vs. placebo volume change 0.031